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ABSTRACT 
Objective: Cancer is considered as one of the top reasons of death and the number of cases increasing gradually. Cancer is severe clinical difficulty 
to the health caution system. This study explored two novel polyphenols of Afrocarpus gracilior Pilger growing in Egypt and evaluated their 
cytotoxic activity.  
Methods: Methanolic (80%) extract of the leaves of A. gracilior was subjected to column chromatography; the chemical structures of the isolated 
compounds were established by advanced spectral techniques: UV, 1H, 13
Results: Two novel C-flavonoid glycosides were isolated [1: Apigenin 8-C-β-D-glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside] and [2: 7-O 
methyl-luteolin 8-C-β-glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside]. They exhibited significant cytotoxic activity (IC
C NMR, two dimensional NMR (2D NMR) and electron spray ionization 
mass spectroscopy (ESI-MS). Compounds 1 and 2 were studied for their cytotoxic activity against hepatocellular carcinoma (Hep-G2) using 
sulforhodamine B (SRB) assay. Furthermore the pharmacokinetics profiles of these molecules were accessed by employing 
Petra/Osiris/Molinspiration (POM) analyses. 
50
Conclusion: These findings demonstrated that the leaves of A. gracilior contain a series of bioactive polyphenolic compounds with significant 
cytotoxic properties against hepatocellular carcinoma and may be used as alternative anticancer agents for doxorubicin. On the basis of POM 
calculations, it will be interesting to develop some alternative flavones because the deglucosylated derivatives have a better drug score than parent 
molecules. This preliminary study will be extended to other strains of cancer. 
 = 9.02 and 15.61 µg/ml, 
respectively) against Hep-G2 cells. The POM analyses revealed that the activity of these two compounds depends on the presence of glucosyl and 
alkyl groups at the internal and terminal atmosphere of the compounds. 
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Cancer affects millions of people worldwide despite of the improved 
molecular diagnostic techniques [1]. Accordingly cancer is a 
clinically serious problem which possesses significant social and 
economic changes to the health care system. Hepatocellular 
carcinoma (HCC) is the fifth most common cancer and the third 
public reason of cancer linked death throughout world [2]. The 
synchronous existence of HCC strength may be due to numerous 
hazard factors such as chronic viral infection diseases with hepatitis 
B virus (HBV) and hepatitis C virus (HCV), aflatoxin exposure, 
alcohol drinking, drugs consumption or iron overload [3, 4]. In 
maximum cases, the recovery proportion from HCC is short and 
existing predictable and adapted therapies are hardly beneficial [5, 
6]. Thus, there is an urgent need for new therapeutic agents for HCC 
patients. A collective means of drug finding is the ethno-medical 
method, in which the choice of a plant is founded on its usage as 
folkloric system. A large number of anti-cancer drugs have been 
extracted from plants containing phenolic compounds as flavonoids, 
tannins, steroid and terpenoids, etc. [7-9]. Plants containing 
polyphenols, flavonoids and/or tannins received considerable 
attention in recent years for their biological activities [10-14]. For 
example some species of Afrocarpus genus (family Podocarpaceae) 
reported to have several biological activities such as antiradical, 
anti-inflammatory, anti-viral, cytotoxic, anti-microbial properties. 
These biological activities were revealed for their contents of 
terpenoid, tannins and flavonoids such as Apigenin 8-C-β-D-
glucopyranosyl-(1```→2``)-O-β-D-glucopyranoside (Vitexin 2``-O-β-
D-glucopyranoside), Quercetin 3-O-β-D-glucopyranoside and II-
4```,I-7-dimethoxyamentoflavone [15-20]. Afrocarpus gracilior (syn. 
Podocarpus gracilior) (Podocarpaceae) (Pg) is an interesting species 
growing in Egypt which has documented as anti-oxidant and 
identified to contain taxol [18, 20-22]. Therefore, the aim of this 
study was to take an overview and to continue isolating the potential 



















































Fig. 1: Chemical structures of two new flavones (1, 2) and standard drug doxorubicin 
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MATERIALS AND METHODS 
Apparatus 
1H and 13C NMR spectra were obtained on a BrukerAPX500 at 500 
and 125 MHz, respectively. The mass spectra (MS) were verified on 
a Waters Acquity Ultra Performance LC with ZQ detector in ESI 
mode. The UV studies for compounds (1 and 2) were measured on a 
Shimadzu UV-240 spectrophotometer, distinctly as solutions in 
methanol and with diagnostic UV shift reagents [23, 24]. Rotary 
evaporator (Bűchi, G, Switzerland) was used for evaporation, 
concentration of extracts and fractions. Fractionation was 
performed by columns chromatography using polyamide 6S (Riedel-
De Hän Ag, Seelze Hannover, Germany), compounds isolation were 
completed on cellulose (Pharmacia, Uppsala, Sweden) and/or 
Sephadex LH-20 (Fluka, Switzerland) columns of diverse dimensions 
and eluted with various mobile phases. Separation procedures were 
monitored up by 2D-PC (two dimensional paper chromatography) 
and CoPC (comparative paper chromatography) using Whatmann 
No. 1 paper with (S1) and (S2) as shown in table 1. Ultraviolet lamp 
(VL-215 LC, Marne La Vallee, France) was used for visualization of 
compounds spots on paper chromatograms and follow up various 
column fractions on columns at 254 or 365 nm and also with located 
(sprayed) Naturstoff and FeCl3 reagents [25].  
Plant material 
Identification of Afrocarpus gracilior Pilger (syn. Podocarpus 
gracilior) confirmed by Dr. Terase Labib, El-Orman Garden, Cairo, 
Egypt. Voucher specimen (Reg. no. 02Pgr/2018) was kept in the 
herbarium of Pharmacognosy Department, Faculty of Pharmacy, 
Helwan University, Cairo, Egypt. 
Spectroscopic data of compounds 1 and 2  
Compound 1:  
Pale yellow amorphous powder (10 mg). Chromatographic 
properties: Rf values; 0.29 (S1), 0.56 (S2); dark purple spot under 
UV-light turned to green colour with FeCl3 and greenish yellow with 
locating reagent (Naturstoff spray). UV-spectral data λmax  (nm) 
(MeOH):272, 301,335; (+NaOMe): 280, 331, 397; (+NaOAc): 280, 
303, 383; (+AlCl3): 275, 302, 345, 387; (+AlCl3/HCl): 276, 301, 345, 
387. 1H NMR (500 MHz, DMSO-d6): δ ppm 13.14 (1H, s, H-bounded 
OH-5), 8.12 (2H, d, J=8.4 Hz, H-2`/6`), 7.06 (2H, d, J=8.4 Hz, H-3`/5`), 
6.64 (1H, s, H-3), 6.46 (1H, s, H-6), 5.06 (1H, d, J=9.9 Hz,H-1``), 4.74 
(1H, d, J=7.4 Hz, H-1```), 3.24-2.67 (remaining of sugar protons). 13C 
NMR (125 MHz, DMSO-d6): δ ppm 182.87 (C-4), 165.86 (C-2), 164.09 
(C-7), 163.59 (C4`), 161.93 (C-5), 157.19 (C-9), 129.72 (C-2`/6`), 
123.58 (C-1`), 116.87 (C-3`/5`), 105.61 (C-10), 104.59 (C-8), 103.59 
(C-3), 101.08 (C-1```), 95.31(C-6), 82.69 (C-5``), 79.59 (C3``), 77.57 
(C-4``), 74.39 (C-5```), 73.44 (C-3```), 72.29 (C-2``), 72.04 (C-1``), 
71.08 (C-2```), 70.90 (C-4```), 62.71 (C-6```), 62.49 (C-6``). Negative 
ESI-MS: m/z 593.4380 [M-H]-, 431.1171 [M-glucosyl]-= [Vitexin-H]-
Yellowish powder (9 mg). Chromatographic properties: R
. 
Compound 2 
f  values: 
0.19 (S1), 0.43 (S2); it is deep purple color under UV-light turned to 
yellow-green on exposure to NH3 vapor. UV-spectral data: λmax  (nm) 
(MeOH): 258, 273, 350; (+NaOMe): 265, 281, 406; (+NaOAc): 260, 
273, 326, 398; (+NaOAc/H3BO3): 260, 272, 383, 429; (+AlCl3): 281, 
302(sh), 331, 430; (+AlCl3/HCl): 264(sh), 279, 296(sh), 360, 385sh. 
1H NMR (500 MHz, DMSO-d6) : δ ppm 12.93 (1H, s, OH-5), 7.91 (1H, d, 
J = 2.4 Hz, H-2`), 7.85 (1H, dd, J = 2.4, 8.1 Hz, H-6`), 6.92 (1H, d, J = 8.1 
Hz, H-5`), 6.62 (1H, s, H-3), 6.49 (1H, s, H-6), 4.99 (1H, d, J = 9.7 Hz, 
H-1``), 4.70 (1H, d, J = 7.8 Hz, H-1```), 3.92 (3H, s, OCH3), 3.89-3.17 
(remaining of sugar protons). 13C NMR (125 MHz, DMSO-d6): δ ppm 
183.42 (C-4), 165.88 (C-2), 162.57 (C-7), 161.73 (C-5), 156.37 (C-9), 
150.55 (C-4`), 146.68 (C-3`), 129.02 (C-6`), 122.89 (C-1`), 116.19 (C-
2`), 116.13 (C-5`), 105.89 (C-10), 105.77 (C-8), 102.77 (C-3), 101.25 
(C-1```), 95.05 (C-6), 80.77 (C-5``), 79.10 (C-3``), 74.12 (C-4``), 73.01 
(C-5```), 71.86 (C-3```), 71.77 (C-2``), 71.25 (C-1``),71.05 (C-4```), 
70.89 (C-2```), 62.87 (C-6```), 61.49 (C-6``), 55.98 (OCH3). Negative 
ESI-MS: m/z 623.1524 [M-H]-, 447.1105 [Orientin-H]-
Cell line and culture medium 
. 
HepG2 cells (ATCC source) were maintained in Roswell Park 
Memorial Institute (RPMI) 1640 medium including 10% heat in-
activated fetal bovine serum supplemented by 100 µg/ml penicillin 
with 100 µg/ml streptomycin at 37 °C under 5% CO2 in air. 
Cytotoxic assay  
The cytotoxic activity of the isolated pure compounds 1 and 2 (fig. 1) 
was carried out according to the method described in literatures [26, 
27]. This colorimetric assay estimates cell number indirectly by 
staining total cellular protein with Sulforhodamine-B (SRB) dye. 
Hep-G2 were seeded in 96-well Fluostar Optima micro-plate at a 
concentration 5 × 104 cells/well in a fresh medium and placed to 
attribute to the well-plate for 24 h at 37 °C in a humidified 
atmosphere of 5% CO2
RESULTS AND DISCUSSION 
. The screened samples (compound 1 and 2) 
were subjected to the wells at diverse concentrations (5, 10, 25, 50 
and 100 µg/ml) using doxorubicin® as standard. The results with 
P<0.05 were observed to be statistically significant. 
Investigation of polyphenolic contents (Extraction and isolation) 
Powdered, air-dried leaves of A. gracilior (1050 g) were exhaustively 
extracted with hot 80% MeOH (5×3 l) under reflux. The dry residue 
obtained (140 g) was extracted with chloroform (3×1 l). The 2D-PC 
revealed that chloroform soluble portion contains limited 
polyphenolic contents, while they were concentrated in methanol 
soluble portion. The aqueous residue (120 g) was fractionated on a 
polyamide column (300 g, Ø 5.5×120 cm) using a step gradient 
H2O/MeOH mixture with decreasing polarity from 100% water to 
MeOH 100% for elution to yield 25 individual fractions, collected 
into four major collective fractions as illustrated previously by 
Kamal et al., 2012 [20]. The third collective fraction eluted by 20-
50% MeOH/H2O was subjected to chromatographic investigation by 
PC (using S1, S2 solvent system) and visualization under UV-light. 
Application of fraction III on cellulose column starting with 20% 
MeOH/H2O then increase % of MeOH to 60% gave 30 sub-fractions. 
The collective major sub-fractions eluted at 50-90% MeOH/H2O 
(using UV light) were collected together. Final purification of these 
sub-fractions by successive fractionation on Sephedex LH-20 column 
using 100% MeOH and S3 solvent system (table 1) resulted in 
chromatographically two pure compounds (1 and 2) identified on 
the basis of acid hydrolysis, comparative PC, UV, ESI-MS, 1H-, 13
  
C-
NMR and 2D-NMR spectroscopic analyses (fig. 2-3). 
 
Apigenin 8-C-β-D-glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside 
or (Vitexin 4``-O-β-D-glucopyranoside) 
Fig. 2: HMBC Structure of compound 1 
 
7-O-methyl-luteolin 8-C-β-glucopyranosyl-(1```→4``)-O-β-D-
glucopyranoside or (4``-glucopyranosyl-7-O-methylorientin) 
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Table 1: Solvent systems 
Solution Mixture of solvents Composition 
S n-Butanol–Acetic acid–Water (BAW) 1 (4:1:5 v/v/v, upper layer) 
S Acetic acid–Water 2 (15:85 v/v) 
SR3 n-Butanol–Isopropyl alcohol–Water (BIW) (4:1:5 v/v/v, upper layer) 
 
Structure elucidation of 1, 2 
The dried residue of 80% MeOH extract, which was extracted with 
chloroform for defatting and aglycones extraction [28] was 
chromatographed on a polyamide column followed by successive 
separation on sephadex LH-20 and cellulose columns affording two 
pure compounds, among which was compound 1, that exhibited 
chromatographic properties, UV-spectral data of C-glycosylapigenin. 
The UV spectrum in MeOH exhibited the two characteristic 
absorption bands at λRmaxR (nm) 272 nm (band II) and 335 nm (Band 
I) of apigenin nucleus. On addition of NaOAc, bathochromic shift of 
band II (≈+7) was diagnostic for free 7 -OH group. The remaining 
diagnostic shift reagents were in complete accordance with 5, 7, 4`-
trihydroxy-C-glycosyl flavones structure [24]. Negative ESI-MS 
spectrum exhibited the molecular ion peak at m/z 593 [M-H]P-
Pcorresponding to M. wt. of 594, molecular formula CR27RHR30RHR15 Rand 
fragment ion peak at m/z 431 after loss of a glycosyl moiety 
indicating apigenin dihexoside structure. P1PHNMR spectrum showed 
an AX coupling system of two ortho douplets, each integrated for 
two protons at δ ppm 8.12 and 7.06 assigned to H2`/6` and H-3`/5`, 
respectively of 1`, 4`-disubstituted ring-B, in addition to the two 
singlet signal resonances at δ ppm 6.64 and 6.46 assignable to H-3 
and H-6, respectively characteristic for an apigenin moiety missing 
H-8 resonance signal. The two anomeric protons appeared as 
doublets at δ ppm 5.06 with large J value 9.9 Hz and 4.74 with J value 
7.4 Hz, gave the suggestion of presence of a C-glucoside and O-
glucoside moieties with a β–linkage, respectively. The absence of H-8 
gave the expectation of C-glucosidation on C-8. This signal was 
established from downfield shift of P13PC-resonance of C-8 to δ ppm 
104.59 (≈+10 ppm) in P13PCNMR spectrum. Moreover, the C-glucoside 
moiety was confirmed as β-glucopyranoside depending on the 
characteristic upfield location of C-1`` at δ ppm 72.04 and downfield 
locations of C-5`` and C-3`` at δ ppm 82.69 and 79.59, respectively 
with respect to those of O-glucoside. The presence of another six 
carbon resonances with the anomeric carbon at δ ppm 101.08 
characteristic for β-O-glucopyranoside structure confirming the 
presence of a second glucose moiety. In addition to, the downfield 
shift of C-4`` at δ ppm 77.57 was an evidence for 1```-4`` intra 
glycosidic linkage. HMBC approved the linkage between the two 
glucosyl moiety glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside 
(fig. 2). All P1PH and P13PC resonances were assigned by comparison with 
the corresponding values of structurally related compounds of 
previously published data [20, 29-33]. In the light of these data 
compound 1 was identified as Apigenin 8-C-β-D-glucopyranosyl-
(1```→4``)-O-β-D-glucopyranoside (Vitexin 4``-O-β-D-glucopyranoside) 
which is isolated for the first time from nature (fig. 2). 
According to the chromatographic properties, compound 2 was 
expected to be a glycosyl luteolin [34]. UV-spectrum in MeOH 
displayed the two distinctive absorption bands I and II of luteolin 
nucleus at λRmaxR 350 and 258 nm, respectively. On addition of NaOAc, 
no bathochromic shift of band II was observed which is diagnostic 
for a substituted 7-OH group. The bathochromic shift of band I in 
AlClR3R together with hypsochromic shift experimental after adding of 
HCl confirmed the occurrence of ortho-dihydroxyl groups at C-3` 
and C-4` in ring B, still the bathochromic shift in band II relative to 
MeOH continued after adding of HCl designated the occurrence of a 
free 5-OH group. On explanation of the given above data and the 
chromatographic properties, compound 2 was expected to be 5,3`,4`-
trihydroxy glycosyl flavone [34, 35]. Negative ESI/MS spectrum 
exhibited the molecular ion peak at m/z 623 [M–H]P- P, corresponding 
to molecular weight of 624 and molecular formula CR28RHR32ROR16R, to 
support evidence of methyl luteolin-di-hexoside structure. In P1PH 
NMR spectrum a flavone compound was confirmed by the 
appearance of a singlet at δ 6.62 for H-3. Additionally, the spectrum 
showed an ABX-spin coupling system of three proton resonances at 
7.91 (H-2`), 7.85 (H-6`), and ortho doublet at 6.92 (H-5`) to indicate 
a 3`,4`-dihydroxy B ring indicating a luteolin nucleus. The absences 
of H-8 signal from the spectrum and the presence of doublets of 
large J-values 9.7 Hz at 4.99 ppm was attributed to anomeric proton 
of C-β-D-glucopyranoside moiety. Another anomeric proton 
appeared as douplets at δ ppm 4.7 with J value 7.8 Hz, gave the 
suggestion of presence of O-glucoside moiety with a β-linkage. As 
further confirmation, P13PC NMR spectrum showed well-resolved 
typical 15 signals of a luteolin aglycone moiety, including the three 
key signals of C-3`, C-4` and C-3 at δ ppm 146.68, 150.55 and 102.77, 
respectively. The downfield shift of P13PC resonance of C-8 to δ 105.77 
was confirmative evidence for the C-glycosidation at C-8. Moreover 
the C-glycoside moiety was confirmed as 8-C-β-glucopyranoside 
depending on the intrinsic upfield location of C-1`` (anomeric 
carbons) at δ 71.25 ppm. The presence of another six carbon 
resonances with the anomeric carbon at δ ppm 101.25 characteristic 
for β-O-glucopyranoside structure confirming the presence of a 
second glucose moiety. HMBC approved the linkage between the two 
glucosyl moiety glucopyranosyl-(1```→4``)-O-β-D-glucopyranoside 
(fig. 3). The presence of carbon resonance at δ 55.98 together with 
The upfield shift of C-7 at 162.57 ppm were indicative for the 
presence of methoxy group attached to C-7 which was approved by 
HMBC spectrum (fig. 3). This structure is confirmed by comparison 
with previous published reports [34-37]. Hence, compound 2 was 
identified as 7-O-methyl-luteolin 8-C-β-glucopyranosyl-(1```→4``)-O-
β-D-glucopyranoside or (4``-glucopyranosyl-7-O-methylorientin), 
which was isolated for the first time from nature (fig. 3). 
Evaluation of cytotoxic activity of 1, 2 
Compounds 1 and 2 showed significant cytotoxic activities against Hep-
G2 hepatocellular carcinoma (ICR50R values 9.02±0.54 and 15.61±1.23 
μg/ml, respectively) compared to doxorubicin as a standard drug (ICR50 
Rvalue 4.47±0.13 μg/ml) as shown in table 2 and fig. 4-5. 
 
Table 2: Comparative bioactivity of compounds 1, 2 and doxurobicin as standard drug 
Bioactivity of compound 1 Bioactivity of compound 2 Bioactivity of doxurobicin 
Conc. (µg/ml) Average SD Conc. (µg/ml) Average SD Conc. (µg/ml) Average SD 
5 0.620333 0.014012 5 0.667667 0.01365 0.5 0.75 0.004583 
10 0.468667 0.020207 10 0.538667 0.017214 1 0.637 0.007937 
25 0.333333 0.007767 25 0.436 0.014 2.5 0.571 0.004 
50 0.184333 0.002517 50 0.306667 0.010066 5 0.481333 0.005508 
100 0.127 0.009165 100 0.214333 0.010599 10 0.306667 0.010066 
 
Antitumor activity of 1, 2 
The effect of both compounds 1 and 2 were tested against Hep-G2 
using the SRB method. SRB dye was used as a stain to estimate cell 
number indirectly [27]. The National Cancer Institute (NCI) 
indicated that the cytotoxicity of a plant extract is considered 
effective with the ICR50R below 20 µg/ml [38]. Compounds 1 and 2 
isolated from P. gracilior have significant cytotoxic activity against 
Kamal et al. 




 values 9.02 and 15.61 µg/ml, respectively (fig. 4 
and 5). Accordingly compounds 1 and 2 could be used as 
chemopreventive agents since recent studies suggested that using 
plant derived chemopreventive agents in combination with 
chemotherapy can increase the usefulness of chemotherapeutic 
agents and lesser their toxicity to normal tissues [39, 40]. 
 
Fig. 4: Cytotoxic activity of compound 1 against Hep-G2 cell line (n = 3) 
 
 
Fig. 5: Cytotoxic activity of compound 2 against Hep-G2 cell line (n = 3) 
 
POM analyses of compounds 1, 2  
A potential drug, should not have only a good bioactivity, it must 
have acceptable pharmacokinetic properties. To access the 
pharmacokinetic profile of molecules, we employed Osiris, Petra and 
Molinspiration (POM) as a good virtual screening with about 7000 
drugs available on the market.  
POM analyses of the standard drug, molecules 1, 2 and their 
deglucosylated derivatives (1’, 2’, 2”) revealed that derivatives of 1, 
2, contrary to reference drug and the two new flavones 1, 2 are more 
active (tables 3, 4). They showed better drug scores and can be 
utilized as therapeutic agents. In fact, structures of the investigated 
anti-cancer drugs are supposed to present some risks when runned 
through the mutagenicity, tumorigenicity assessments, and that 
these two compounds were at low risk comparable with standard 
drug (SD) as near as irritation and reproductive effects are 
concerned.  
For example, acute side-effects of doxorubicin include vomiting, 
nausea, and heart arrhythmias. It can also causes neutropenia 
(reduction in white blood cells) and alopecia (hair loss). An 
increasing dose of doxorubicin is capable to lead the patient to 
severe risks of developing cardiac side effects; including congestive 
heart failure, dilated cardiomyopathy, and death, powerfully rise. 
Reactive oxygen species (ROS), formed by the contact of doxorubicin 
with iron, can then harm the myocytes (heart cells), creating 
myofibrillar loss and cytoplasmic vacuolization [41].  
The hydrophilicity character of each constituent had been stated in 
terms its cLogP value since it had been recognized that the 
absorption or permeation is importantly affected by this quantity 
(value of cLogP). Therefore, when the value of cLogP is greater than 
5, the absorption or permeation decreases. Our results showed that 
the new compounds (1 and 2) have similar cLogP of those of the 
anti-tumor standard drug SD, within the acceptable criteria. As the 
molecular weight of all parent molecules (1, 2 and SD) is 594-
624>500 g, it is necessary to realize more chemical modification 
(deglucosylation) in goal to make more potentially active analogues. 
The actual drug-scores of compounds 1 and 2 are very encouraging 
(positive value of DS) as shown in table 4. 
  
Table 3: Molinspiration calculations of compounds 1, 2 and doxorubicin 
Compound Molecular properties  [a] Bioactivity scores [b] 
TPSA ONH VIOL VOL  GPCR ICM KI NRL PI EI 
1 260 10 3 487  0.10 -0.45 -0.01 -1.04 0.06 -0.28 
2 269 10 3 513  0.01 -0.68 -0.16 -1.32 -0.04 0.11 
SD P[c] 209 8 3 465  0.27 -0.14 0.08 0.24 0.56 0.64 
P
[a]
PTPSA: 1T otal of Polar surface area; ONH: OH—N or O—HN Interaction; VOL: Volume, 1TP[b]PGPCR: GPCR ligand; ICM: Ion channel modulator; KI: Kinase inhibitor; 
NRL: Nuclear receptor ligand; PI: Protease inhibitor; EI: Enzyme inhibitor., P[c]PStandard drug: (SD = Doxorubicin). Structure of SD is given in fig. 1.  
Kamal et al. 
Int J Pharm Pharm Sci, Vol 11, Issue 7, 57-62 
61 
Table 4: Molinspiration prediction of compounds 1, 2 and doxorubicin and their hypothetic derivatives (1’, 2’, 2”, SD’ and SD”) 
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The methanolic extract of the leaves of A. gracilior contains a 
considerable amount of polyphenolic compounds that have 
significant cytotoxic properties and thus have great potential as a 
source for natural health products. The POM analyses revealed that 
the activity of compounds 1, 2 and standard drug (SD) depended on 
the presence of glucosyl and alkyl groups at the internal and 
terminal atmosphere of the compounds. The docking analysis 
revealed that lipophilic and H-bonding interactions were the 
prominent interactions among flavones and the Cancer-DNA 
receptor. The POM Analyses of compounds 1, 2 and SD proved to be 
a useful tool in the prediction of anti-tumor activity of congeneric 
compounds and some important insights were also originate that 
will be useful to monitor for the prediction of new cancer inhibitors 
with enhanced bio-activity. 
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